Bangalore (Karnataka) [India], March 13: Foundation for Neglected Disease Research (FNDR) Bangalore and Blockchain For Impact (BFI) announced an impact driven partnership under the BFI-Biome Virtual Network Program, aimed at advancing healthcare in India. BFI aims to allocate 300,000 USD to
Ahmedabad (Gujarat) [India], February 23: Gujarat based Vivanza Biosciences Ltd (BSE - 530057) - engaged in the business of pharmaceuticals and agro trading has reported excellent financial results for the nine months ended December 2023. Company reported consolidated total income of Rs. 23.
Union Minister of Health and Family Welfare, Mansukh Mandaviya, inaugurated five new facilities at the Indian Council of Medical Research - National Institute of Malaria Research (ICMR-NIMR) in Delhi on Thursday.
New Delhi [India], November 18: TiE Delhi-NCR announced its partnership with Prayatna to host an IT-enabled innovation-based Hackfest, the 'Malaria Hackfest - Predict, Plan & Prevent', powered by Mortein. With this initiative, TiE Delhi-NCR in partnership with Prayatna is seeking solutio
Many species of bacteria have been discovered by Indiana University School of Medicine researchers to be connected with an increased risk of severe malaria in humans and mice when present in the stomach.
Researchers at Indiana University School of Medicine have found many types of bacteria that, when present in the stomach, are associated with an elevated risk of getting severe malaria in humans and mice. Their findings, which were recently published in Nature Communications, could pave the
"I walk two or three streets twice a day, morning and evening, spraying mosquito repellent as much as I can. This makes my heart happy and I am appreciated by all the public," he told ANI.
As malaria vaccine developed by the University of Oxford and the Serum Institute of India (SII) has been recommended for use by the World Health Organisation (WHO), SII chief Adar Poonawalla said that the combined efforts of both of them have come to fruition.
The R21/Matrix-M malaria vaccine developed by the University of Oxford and the Serum Institute of India has been recommended for use by the World Health Organisation (WHO) after meeting required safety, quality and effectiveness standards.
The recommendation follows advice from the WHO: Strategic Advisory Group of Experts on Immunisation (SAGE) and the Malaria Policy Advisory Group (MPAG) and was endorsed by the WHO Director-General following its regular biannual meeting held on September 25-29.